Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 9.70
-0.15 (-1.52%)
Jul 28, 2026, 8:33 AM GMT
Abingdon Health Cash Flow Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -3.24 | -3.42 | -1.27 | -3.47 | -21.26 | -6.97 |
Depreciation & Amortization | 0.69 | 0.6 | 0.43 | 0.77 | 8.83 | 0.75 |
Stock-Based Compensation | 0.3 | 0.21 | 0.05 | 0.03 | 0.23 | 1.37 |
Other Adjustments | -0.16 | -0.27 | -0.35 | -0.42 | 9.5 | 0.05 |
Change in Receivables | -0.47 | -0.62 | -0.3 | 6.65 | 2.13 | -8.1 |
Changes in Inventories | -0.19 | -0.09 | -0.11 | 0.21 | -2.32 | -7.11 |
Changes in Accounts Payable | 0.58 | 0.17 | -0.34 | -3.18 | -5.17 | 7.03 |
Changes in Income Taxes Payable | 0.23 | 0.23 | 0.23 | 0.33 | 0.32 | 0.11 |
Operating Cash Flow | -2.27 | -3.18 | -1.66 | 0.91 | -7.74 | -12.88 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Capital Expenditures | -0.35 | -0.33 | -0.04 | -0.08 | -0.68 | -6.76 |
Sale of Property, Plant & Equipment | - | - | - | 0 | - | 0.01 |
Purchases of Intangible Assets | -0.02 | -0.02 | -0.01 | -0.08 | -0.08 | -0.49 |
Purchases of Investments | - | - | -0.01 | - | - | - |
Cash Acquisitions | - | -1.18 | - | - | - | -0.03 |
Other Investing Activities | 0.07 | 0.1 | 0.03 | 0.09 | 0 | - |
Investing Cash Flow | -0.3 | -1.43 | -0.02 | -0.07 | -0.76 | -7.28 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Long-Term Debt Issued | - | - | - | 0.25 | 0.17 | 0.27 |
Long-Term Debt Repaid | - | - | - | -0.12 | -0.13 | -0.02 |
Net Long-Term Debt Issued (Repaid) | - | - | - | 0.14 | 0.04 | 0.25 |
Issuance of Common Stock | 3.45 | 5.63 | - | - | 6.14 | 20.7 |
Net Common Stock Issued (Repurchased) | 3.45 | 5.63 | - | - | 6.14 | 20.7 |
Other Financing Activities | -0.84 | -0.55 | -0.11 | -0.14 | -0.26 | -0.21 |
Financing Cash Flow | 2.61 | 5.08 | -0.11 | -0.01 | 5.92 | 20.74 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Foreign Exchange Rate Adjustments | -0.01 | 0 | - | - | - | - |
Net Cash Flow | 0.04 | 0.47 | -1.8 | 0.84 | -2.58 | 0.59 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -2.62 | -3.51 | -1.69 | 0.84 | -8.42 | -19.64 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -27.36% | -41.63% | -27.61% | 20.72% | -297.04% | -169.02% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | 0.00 | -0.03 | -0.07 |
Levered Free Cash Flow | -2.29 | -2.83 | -1.1 | -5.29 | -20.24 | -12.7 |
Unlevered Free Cash Flow | -2.28 | -2.84 | -1.07 | -5.43 | -20.22 | -12.72 |